Spitz Technologies Corporation v. Nobel Biocare USA LLC

District Court, C.D. California·Decided March 25, 2021·No. 8:17-cv-00660-JVS-JCG·Unknown

Opinion

DON HOWARTH, Bar No. 53783 JOHN B. SGANGA, JR., Bar No. 116211 dhowarth@howarth-smith.com john.sganga@knobbe.com PADRAIC J. GLASPY, Bar No. 259563 SHEILA N. SWAROOP, Bar No. 203476 pglaspy@howarth-smith.com sheila.swaroop@knobbe.com HOWARTH & SMITH KNOBBE, MARTENS, OLSON & BEAR, 523 West Sixth Street, Suite 728 LLP Los Angeles, California 90014 2040 Main Street, Fourteenth Floor Telephone: (213) 955-9400 Irvine, California 92614 Facsimile: (213) 622-0791 Telephone: (949) 760-0404 Facsimile: (949) 760-9502 Attorneys for Plaintiff SPITZ TECHNOLOGIES Attorneys for Defendant

FOR THE CENTRAL DISTRICT OF CALIFORNIA Case No. 8:17-cv-00660-JVS-JCG CORPORATION, Hon. James V. Selna Plaintiff, STIPULATION AND [PROPOSED] v. ORDER TO MODIFY NOBEL BIOCARE USA, LLC, Defendant.

NOBEL BIOCARE USA, LLC (“Nobel”), on the one hand, and SPITZ TECHNOLOGIES CORPORATION (“Spitz”), on the other hand, by and through their counsel below, hereby stipulate as follows:

WHEREAS, on or about April 11, 2017, Spitz filed a lawsuit in this Court against Nobel as the above-entitled action (the “Nobel Action”); WHEREAS, Spitz was represented in the Nobel Action by the law firm

Michelman & Robinson, LLP (“Michelman”) and by the Quinn Emanuel law firm (“Quinn”); WHEREAS, this Court entered a Protective Order in this case on or about July 6, 2017, at Docket No. 28 (the “Protective Order”), which is incorporated by

reference herein; WHEREAS, the Protective Order governed, in part, the protection of certain documents produced in the course of the Nobel Action that were designated by the

parties as “CONFIDENTIAL BUSINESS INFORMATION”, and the use and disclosure of documents and information so designated (“Protected Material”) was restricted, including the restriction that said documents could only be used or disclosed “only for prosecuting, defending, or attempting to settle this Action” and

that such documents “may be disclosed only to the categories of persons and under the conditions described in this Order” [Dkt. 28 at ¶ 7.1]; WHEREAS, in the course of the Nobel Action, the parties did in fact produce

documents that were designated by the party producing them as “CONFIDENTIAL BUSINESS INFORMATION” under the Protective Order; WHEREAS, the Nobel Action was dismissed on or about September 6, 2019; WHEREAS, after the resolution of the Nobel Action, Spitz has advised that a

potential dispute arose between Spitz and Michelman relating to this litigation; WHEREAS, Spitz has advised that, in the course of assessing its potential claims against Michelman, Spitz made a request for, and Michelman purported to

produce its client file for the Nobel Action, which file included documents produced under and subject to the protections of the Protective Order entered by the Court in this litigation; WHEREAS, the terms of the Protective Order remain in full force and effect as

to the documents and information that were produced pursuant to it; WHEREAS, Spitz has advised that it is represented in assessing its potential claims by the law firm Howarth & Smith;

WHEREAS, under the terms of the Court’s Protective Order, neither Howarth & Smith, nor any experts retained thereby, nor any mediator, arbitrator, or Court who may preside over the litigation of the dispute between Spitz and Michelman are permitted to obtain and review the documents designated under the Protective Order

because any disclosure or use of the documents would not be in connection with the Nobel Action, and because such parties do not fit into the categories of individuals permitted to view such documents under the Protective Order;

WHEREAS, Spitz has advised that documents designated by Nobel as Protected Material are part of the client file owned by Spitz and are relevant to assessment of the Spitz claims and to the issues in the dispute between Spitz and Michelman;

WHEREAS, in order to minimize burden to Nobel, the parties to the Court’s Protective Order and their respective counsel, agree that the terms of the prior Protective Order should be modified to permit the use of documents designated by

Nobel as Protected Material in connection with Spitz’s potential claims against Michelman; WHEREAS, federal courts have jurisdiction to modify protective orders that they issue where they are still in force and effect, even after a judgment is final on a

case. See, e.g., Public Citizen v. Liggett Group, Inc., 858 F.2d 775, 782–783 (1st Cir. 1988) (“we find that, because the protective order was still in effect, the district court had the power to make postjudgment modifications to the protective order”); FDIC v.

Ernst & Ernst, 677 F.2d 230 232 (2d Cir.1982); Krause v. Rhodes, 671 F.2d 212 (6th Cir.), cert. denied, 459 U.S. 823, 103 S.Ct. 54 (1982); United States v. GAF Corp., 596 F.2d 10, 16 (2d Cir.1979); American Telephone & Telegraph Co. v. Grady, 594 F.2d 594, 596–97 (7th Cir.1978), cert. denied, 440 U.S. 971, 99 S.Ct. 1533 (1979);

Olympic Refining Co. v. Carter, 332 F.2d 260, 265–66 (9th Cir.), cert. denied, 379 U.S. 900 (1964); Marcus, Myth and Reality in Protective Order Litigation, 69 Cornell L. Rev. 1, 41–53 (1983); Note, Nonparty Access to Discovery Materials in Federal

Court, 94 Harv. L. Rev. 1085, 1091–96 (1981); and WHEREAS, good cause exists for this Court to enter the modifications to the Protective Order [Dkt. 28], incorporated herein.

HEREBY STIPULATE AS FOLLOWS: 1. The July 6, 2017 Protective Order entered by this Court in the Nobel Action [Dkt. 28] shall be amended and modified as provided herein below to allow

for the use of documents designated by Nobel as containing Protected Material and produced thereunder in connection with the dispute between Spitz and Michelman, provided that Nobel is provided with notice of and has the ability to approve of disclosure of its Protected Material prior to such disclosure being made, as set forth

below. 2. All provisions of the Court’s prior Protective Order not amended, modified, or inconsistent with the provisions herein shall remain in full force and

effect. 3. Information and/or documents that were designated by Nobel under the Protective Order as “CONFIDENTIAL BUSINESS INFORMATION” may be used for the limited purpose of evaluating, assessing, prosecuting, defending, or attempting

to settle the dispute between Spitz and Michelman. Such use of Protected Material designated by Nobel shall be limited to the categories of persons and under the conditions described in the Protective Order and this Stipulation and Modification.

/ / / 4. Information and/or Documents that were designated under the Protective Order as “CONFIDENTIAL BUSINESS INFORMATION” may be disclosed to the following persons:

(a) outside counsel representing Spitz (the Howarth & Smith firm), Michelman, and any insurers thereof, including all paralegal assistants, secretarial and stenographic and clerical employees working under the

supervision of such counsel, which outside counsel (with the exception of the Howarth & Smith firm identified above) shall be identified to Nobel prior to the disclosure of any CONFIDENTIAL BUSINESS INFORMATION, and provided such outside counsel that has not signed

Free access — add to your briefcase to read the full text and ask questions with AI

Spitz Technologies Corporation v. Nobel Biocare USA LLC, (C.D. Cal. 2021).

Spitz Technologies Corporation v. Nobel Biocare USA LLC (Spitz Technologies Corporation v. Nobel Biocare USA LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Krause v. Rhodes
671 F.2d 212 (Sixth Circuit, 1982)
Public Citizen v. Liggett Group, Inc.
858 F.2d 775 (First Circuit, 1988)
Wallace & Tiernan Co. v. Village of Le Roy
17 F.2d 593 (W.D. New York, 1927)
Olympic Refining Co. v. Carter
332 F.2d 260 (Ninth Circuit, 1964)